Cameroon [clinicaltrials_resource:4be25f9d27da71d4e98775668b5b12af]
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV [clinicaltrials:NCT00122486]Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women [clinicaltrials:NCT00136643]Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon [clinicaltrials:NCT00209313]Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon [clinicaltrials:NCT00297882]Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL) [clinicaltrials:NCT00301561]ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria [clinicaltrials:NCT00316329]Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria [clinicaltrials:NCT00442403]Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) [clinicaltrials:NCT00442845]Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance [clinicaltrials:NCT00445796]Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria [clinicaltrials:NCT00484900]ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome [clinicaltrials:NCT00489333]ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency [clinicaltrials:NCT00493506]clinicaltrials:NCT00573001Malarial Immunity in Pregnant Cameroonian Women [clinicaltrials:NCT00593398]Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome [clinicaltrials:NCT00645775]Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon [clinicaltrials:NCT00658346]Treat Arterial Hypertension and Diabetes in Rural Africa [clinicaltrials:NCT00744458]Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malaria [clinicaltrials:NCT00978172]clinicaltrials:NCT01030458Lepticore in Metabolic Syndrome and Weight Loss [clinicaltrials:NCT01046968]" Arthrospira Platensis" as Nutrition Supplementation for Female Adult Patients Infected by HIV in Yaoundé Cameroon [clinicaltrials:NCT01084382]The Effects of Spirulina Platensis on Insulin Resistance in HIV-infected Patients [clinicaltrials:NCT01141777]Cameroon Mobile Phone SMS Trial [clinicaltrials:NCT01247181]Research on the Economics of Artemisinin Combination Therapy (ACTs) for the Treatment of Malaria [clinicaltrials:NCT01350752]Improving Access to HbA1c in Sub Saharan Africa [clinicaltrials:NCT01460095]Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries [clinicaltrials:NCT01494961]Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients [clinicaltrials:NCT01540240]Post-Treatment Side Effects of Ivermectin or DEC for Loa Loa Infection [clinicaltrials:NCT01593722]clinicaltrials:NCT01709084Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon [clinicaltrials:NCT01845701]Effectiveness of Nutritional Products to Treat Moderate Acute Malnutrition [clinicaltrials:NCT01898871]Collaborative Wilms Tumour Africa Project [clinicaltrials:NCT01991652]clinicaltrials:NCT02031315Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project [clinicaltrials:NCT02043418]Epidemiology of Sudden Cardiac Arrest in Sub-Saharan Africa: Rationale and Design [clinicaltrials:NCT02142270]Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDS [clinicaltrials:NCT02155101]Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa [clinicaltrials:NCT02192658]Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension [clinicaltrials:NCT02426099]
country [clinicaltrials_vocabulary:country]
Cameroon [clinicaltrials_resource:4be25f9d27da71d4e98775668b5b12af]
Bio2RDF identifier
4be25f9d27da71d4e98775668b5b12af
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4be25f9d27da71d4e98775668b5b12af
identifier
clinicaltrials_resource:4be25f9d27da71d4e98775668b5b12af
title
Cameroon
@en
type
label
Cameroon [clinicaltrials_resource:4be25f9d27da71d4e98775668b5b12af]
@en